Dr. Morgenstern is a strong advocate of combining cutting-edge research with quality patient care. He currently divides his time between directing an active treatment research program that has been funded by the National Institutes of Health for the last 16 years and overseeing the Substance Abuse Treatment Program at NYPH.

Dr. Morgenstern's interests include testing the effectiveness of manualized evidence-based behavioral interventions in community settings. He conducted one of the first effectiveness studies examining CBT and was Co-PI on an effectiveness study of Motivational Interviewing. In addition, he is interested in alternative bi-directional models that foster science-to-practice such as those that have been used successfully in the area of welfare practice and policy. He is currently PI on four studies whose broad aims include developing and testing novel interventions that coordinate social services, health care, and substance abuse treatment for economically disadvantaged substance abusers.